Literature DB >> 23262432

Double homozygous missense mutations in DACH1 and BMP4 in a patient with bilateral cystic renal dysplasia.

Raphael Schild1, Tanja Knüppel, Martin Konrad, Carsten Bergmann, Agnes Trautmann, Markus J Kemper, Kongming Wu, Sergey Yaklichkin, Jing Wang, Richard Pestell, Dirk E Müller-Wiefel, Franz Schaefer, Stefanie Weber.   

Abstract

Renal hypodysplasia (RHD) is characterized by small and/or disorganized kidneys following abnormal organogenesis. Mutations in several genes have been identified recently to be associated with RHD in humans, including BMP4, a member of the transforming growth factor (TGF)-β family of growth factors. DACH1 has been proposed as a candidate gene for RHD because of its involvement in the EYA-SIX-DACH network of renal developmental genes. Here, we present a patient with renal dysplasia carrying homozygous missense mutations in both BMP4 (p.N150K) and DACH1 (p.R684C). The genotype-phenotype correlation in the family hints at an oligogenic mode of inheritance of the disease in this kindred. Functional analyses of the identified DACH1 mutation in HEK293T cells demonstrated enhanced suppression of the TGF-β pathway suggesting that both mutations could act synergistically in the development of the phenotype in this patient. This finding provides a model for RHD as an oligo-/polygenic disorder and supports a role for DACH1 in the development of RHD in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23262432      PMCID: PMC3616761          DOI: 10.1093/ndt/gfs539

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  22 in total

1.  Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis.

Authors:  Xue Li; Kenneth A Oghi; Jie Zhang; Anna Krones; Kevin T Bush; Christopher K Glass; Sanjay K Nigam; Aneel K Aggarwal; Richard Maas; David W Rose; Michael G Rosenfeld
Journal:  Nature       Date:  2003-11-20       Impact factor: 49.962

2.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

Review 3.  Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT.

Authors:  Iekuni Ichikawa; Fumiyo Kuwayama; John C Pope; F Douglas Stephens; Yoichi Miyazaki
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

4.  Dach1 mutant mice bear no gross abnormalities in eye, limb, and brain development and exhibit postnatal lethality.

Authors:  R J Davis; W Shen; Y I Sandler; M Amoui; P Purcell; R Maas; C N Ou; H Vogel; A L Beaudet; G Mardon
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter.

Authors:  Y Miyazaki; K Oshima; A Fogo; B L Hogan; I Ichikawa
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  DACH: genomic characterization, evaluation as a candidate for postaxial polydactyly type A2, and developmental expression pattern of the mouse homologue.

Authors:  J A Ayres; L Shum; A N Akarsu; R Dashner; K Takahashi; T Ikura; H C Slavkin; G H Nuckolls
Journal:  Genomics       Date:  2001-09       Impact factor: 5.736

7.  BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance.

Authors:  Nicholas Katsanis; Erica R Eichers; Stephen J Ansley; Richard Alan Lewis; Hülya Kayserili; Bethan E Hoskins; Peter J Scambler; Philip L Beales; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-05-15       Impact factor: 11.025

8.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

9.  Steroid-resistant nephrotic syndrome and congenital anomalies of kidneys: evidence of locus on chromosome 13q.

Authors:  Abhay N Vats; Chandra Ishwad; Kalyani R Vats; Michael Moritz; Demetrius Ellis; Christine Mueller; Urvashi Surti; Maria Z Parizhskaya; Manuel P Meza; Leah Burke; Francis X Schneck; Malika Saxena; Robert Ferrell
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

10.  Molecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein.

Authors:  Keiko Ikeda; Yoko Watanabe; Hiromi Ohto; Kiyoshi Kawakami
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more
  13 in total

Review 1.  Interplay of retinal determination gene network with TGF-β signaling pathway in epithelial-mesenchymal transition.

Authors:  Yu Liu; Deguang Kong; Hua Wu; Xun Yuan; Hanxiao Xu; Cuntai Zhang; Gaosong Wu; Kongming Wu
Journal:  Stem Cell Investig       Date:  2015-06-09

2.  DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.

Authors:  Aili Cao; Jianhua Li; Morad Asadi; John M Basgen; Bingbing Zhu; Zhengzi Yi; Song Jiang; Tomohito Doke; Osama El Shamy; Niralee Patel; Paolo Cravedi; Evren U Azeloglu; Kirk N Campbell; Madhav Menon; Steve Coca; Weijia Zhang; Hao Wang; Ke Zen; Zhihong Liu; Barbara Murphy; John C He; Vivette D D'Agati; Katalin Susztak; Lewis Kaufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

Review 3.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

Review 4.  Novel Insights into the Pathogenesis of Monogenic Congenital Anomalies of the Kidney and Urinary Tract.

Authors:  Amelie T van der Ven; Asaf Vivante; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2017-10-27       Impact factor: 10.121

5.  DACH1 as a multifaceted and potentially druggable susceptibility factor for kidney disease.

Authors:  Sandra Merscher; Christian Faul
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 19.456

6.  Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis.

Authors:  Tomohito Doke; Shizheng Huang; Chengxiang Qiu; Hongbo Liu; Yuting Guan; Hailong Hu; Ziyuan Ma; Junnan Wu; Zhen Miao; Xin Sheng; Jianfu Zhou; Aili Cao; Jianhua Li; Lewis Kaufman; Adriana Hung; Christopher D Brown; Richard Pestell; Katalin Susztak
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 19.456

7.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases.

Authors:  Richard N Wang; Jordan Green; Zhongliang Wang; Youlin Deng; Min Qiao; Michael Peabody; Qian Zhang; Jixing Ye; Zhengjian Yan; Sahitya Denduluri; Olumuyiwa Idowu; Melissa Li; Christine Shen; Alan Hu; Rex C Haydon; Richard Kang; James Mok; Michael J Lee; Hue L Luu; Lewis L Shi
Journal:  Genes Dis       Date:  2014-09

8.  Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity.

Authors:  Qing-Quan Liu; Ya-Qun Zhou; Hui-Quan Liu; Wen-Hui Qiu; Hui Liu; Ting-Yang Hu; Qing Xu; Yong-Man Lv; Kong-Ming Wu
Journal:  Oncotarget       Date:  2016-12-27

Review 9.  The regulation of cytokine signaling by retinal determination gene network pathway in cancer.

Authors:  Xinhua Zheng; Qian Liu; Ming Yi; Shuang Qin; Kongming Wu
Journal:  Onco Targets Ther       Date:  2018-10-04       Impact factor: 4.147

Review 10.  The retinal determination gene network: from developmental regulator to cancer therapeutic target.

Authors:  Deguang Kong; Yu Liu; Qian Liu; Na Han; Cuntai Zhang; Richard G Pestell; Kongming Wu; Gaosong Wu
Journal:  Oncotarget       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.